Pharmaceutical Technology on MSN

JPM26: Vertex hopes to match cystic fibrosis success in pain and kidney disease

Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.
Seeking Alpha

Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (VRTX) (Nasdaq: VRTX) today announced that the company has partnered with basketball world champion Jayson Tatum to raise awareness of ...